Biotech News
Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses
– Strengthens Charles River's Bioanalysis and DMPK Capabilities to Support Clients Across the Drug Development Lifecycle – – Advances Pathway to Purpose Strategy and Enhances Long-Term Growth and Value Creation – WILMINGTON, Mass. --(BUSINESS WIRE)--Nov.
